Redeye expects another quarter with high activity in terms of deliveries and reported sales.
Redeye updates its estimates and valuation after OEM’s Q3 2025 report.
Organic growth could return in Q3 y/y after being negative for the past seven quarters.
* Q3e EBITDA of NOK 9m * Awaiting stabilised markets * '26e-'27e estimates down - DCF NOK 15/sh Q3e ...
Hanza briserade under onsdagskvällen ut förvärvet av tyska BMK.
Redeye shares its preview of BONESUPPORT’s Q3 2025 results, due October 23.
Interim CEO Jyri Luomakoski has been appointed as new CEO of the company.
Redeye shares its preview of Xvivo’s Q3 2025 results, due October 23.
Redeye comments on the news that Egetis has secured an agreement for Emcitate in the Gulf region.
Duell’s Q4 results were mixed, with the Nordics outperforming expectations while Central Europe fell...
Raute reports Q3 results on Oct 30. Earnings are likely to peak at least temporarily this year, but ...
Redeye comments on Waystream’s Q3 report, which showed solid double-digit organic growth coupled wit...
Redeye sees a solid Q3 report from Carasent with slightly lower ARR growth but better cost control t...
* Qben Infra, MCap of SEK 846m, selling 100% of Rail.
* Strong Q3: EBIT SEK 48m (vs. SEK -23m Q3'24) * We raise our EPS assumptions, but cut '25e EBIT on ...
Suominen lowered its guidance today and now expects 2025 adjusted EBITDA to be lower compared to 202...
* Report out on 7 November * Q3e sales of EUR 40m (44m), EBIT EUR 2.
Analysguiden räknar med en omsättning om 2 mdkr och ett justerad rörelseresultat om 280 mkr för Beij...
Suominen reports Q3 results on Oct 29. H1’25 saw an earnings recovery setback so that H2 must show m...
* Report out on 4 November * Q3e sales of SEK 225m (+12% y-o-y), EBIT adj.
